The purpose of this study is to evaluate the efficacy and safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
Over 19 years old
Type 2 diabetes mellitus
Patient who has been taking oral hypoglycemic agents for over 8 weeks
Agreement with written informed consent
Type 1 diabetes mellitus or secondary diabetes mellitus
Patients with complications of severe diabetes such as proliferative diabetic retinopathy
Patients with genetic problems such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption
Patients with abnormal laboratory test results according to the protocol